MYC and colorectal cancer: In addition, hsa-mir-30d overexpression inhibits the activation of cyclin D1, cMyc, and catenin, three essential components of the Wnt/beta-catenin signaling pathway, thereby inhibiting the development of colorectal cancer [71].